6+00:00","flyer_link":null,"image_name":"https://imagedelivery.net/446RhcKSmHi3fzbXKA91IQ/989f4e9c-0a35-40fb-a1d8-53c3fb416800/public","meta_title":"","start_date":"2026-05-16T07:00:00+00:00","updated_at":null,"description":"$22","is_cfp_conf":null,"is_published":true,"accreditations":null,"additional_tax":null,"exhibitor_link":null,"homepage_image":"https://imagedelivery.net/446RhcKSmHi3fzbXKA91IQ/989f4e9c-0a35-40fb-a1d8-53c3fb416800/public","additional_info":"","target_audience":"

Medical Oncologists
Surgeons
Radiation Oncologists,
Pathologists
Oncology Fellows
Oncology Nurses
Nurse Practitioners
Physician Assistants
Pharmacists

","meta_description":"","calculated_credit":null,"learning_objectives":"

Upon successful completion of this educational activity, participants will be able to:

Evaluate actionable molecular alterations in lung cancer and select appropriate diagnostic testing strategies to guide targeted treatment decisions.
Compare the efficacy, safety, and sequencing considerations of immune checkpoint inhibitors, targeted therapies, and cytotoxic chemotherapy in the management of NSCLC and SCLC.
Assess the role of perioperative and curative-intent systemic therapies in early-stage NSCLC, including chemotherapy, immunotherapy, and targeted agents.
Integrate emerging clinical evidence and advances in precision oncology into personalized treatment paradigms for patients with thoracic malignancies.

","organizing_committee":"

Course Director:

Binay Shah, MD, MHA - Binaytara

Conference Co-Chairs:

Millie Das - Stanford University
Dron Gauchan - Sutter Health
Matthew Gubens - UCSF

","price_additional_info":null,"accreditation_additonal_info":null},"programData":[{"id":1771266048891,"title":"Registration, Breakfast, & Exhibits ","start":"2026-05-16T14:00:00.000Z","end":"2026-05-16T15:00:00.000Z","description":null,"raw_faculty":[],"faculty":[],"type":["break"],"parentId":null,"isCmeAccredited":false},{"id":1771266072190,"title":"Welcome & Opening Remarks","start":"2026-05-16T15:00:00.000Z","end":"2026-05-16T15:05:00.000Z","description":null,"raw_faculty":[],"faculty":[],"type":["welcome"],"parentId":null,"isCmeAccredited":false},{"id":1771266090847,"title":"Progress in Targeted Therapy","start":"2026-05-16T15:05:00.000Z","end":"2026-05-16T16:35:00.000Z","description":null,"raw_faculty":[],"faculty":[],"type":["session"],"parentId":null,"isCmeAccredited":true},{"id":1771266116676,"title":"Session 2: New Targets & Treatments in Oncogene Driven Lung Cancer","start":"2026-05-16T16:35:00.000Z","end":"2026-05-16T17:20:00.000Z","description":null,"raw_faculty":[],"faculty":[],"type":["session"],"parentId":null,"isCmeAccredited":true},{"id":1771266147449,"title":"Break & Exhibits","start":"2026-05-16T17:20:00.000Z","end":"2026-05-16T17:40:00.000Z","description":null,"raw_faculty":[],"faculty":[],"type":["break"],"parentId":null,"isCmeAccredited":false},{"id":1771266192047,"title":"Lunch & Exhibits","start":"2026-05-16T19:00:00.000Z","end":"2026-05-16T20:00:00.000Z","description":null,"raw_faculty":[],"faculty":[],"type

Conferences

Organizing Committee:

Target Audience:

Learning Objectives: